These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34365491)

  • 21. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of psychoactive substance use among commercial motorcyclists and its health and social consequences in Zaria, Nigeria.
    Alti-Muazu M; Aliyu AA
    Ann Afr Med; 2008 Jun; 7(2):67-71. PubMed ID: 19143162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phantom menace: novel psychoactive substances and the UK Armed Forces.
    Hunter AH; Ayres T; Moreland N; Cox A
    J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza.
    Martinotti G; Cinosi E; Santacroce R; Papanti D; Pasquini A; Mancini V; Corbo M; Fiori F; Sarchione F; Marchetti D; Verrocchio MC; Di Giannantonio M; Torrens M; Schifano F; Morlan Coarasa MJ; Merino Del Villar C
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28557062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New/emerging psychoactive substances and associated psychopathological consequences.
    Schifano F; Napoletano F; Chiappini S; Guirguis A; Corkery JM; Bonaccorso S; Ricciardi A; Scherbaum N; Vento A
    Psychol Med; 2021 Jan; 51(1):30-42. PubMed ID: 31327332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.
    Deligianni E; Daniel OJ; Corkery JM; Schifano F; Lione LA
    Br J Clin Pharmacol; 2020 Mar; 86(3):505-516. PubMed ID: 31495968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE; Teesson M; Newton NC
    Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.
    Tanti M; Cosgrove J; Kelleher C; Jones R; Maguire M
    Clin Med (Lond); 2021 May; 21(3):189-194. PubMed ID: 33947659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
    Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
    Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring new psychoactive substances: Exploring the contribution of an online discussion forum.
    Rhumorbarbe D; Morelato M; Staehli L; Roux C; Jaquet-Chiffelle DO; Rossy Q; Esseiva P
    Int J Drug Policy; 2019 Nov; 73():273-280. PubMed ID: 30967328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.
    Corazza O; Assi S; Malekianragheb S; Beni MN; Bigdeli I; Aslanpour Z; Schifano F
    Int J Drug Policy; 2014 Jul; 25(4):724-6. PubMed ID: 24917190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotic-Like Experiences and Concurrent Substance Use Among People Who Use New Psychoactive Substances.
    Ellilä V; Levola J; Denissoff A; Partanen M; Niemelä S
    Subst Use Misuse; 2023; 58(12):1606-1614. PubMed ID: 37482647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New psychoactive substances abuse among patients with access to methadone maintenance treatment in Jiangsu province: a case-control study].
    Cheng Z; Chen GH; Dai MM; Luo W; Lyu P; Cao XB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):625-630. PubMed ID: 29860806
    [No Abstract]   [Full Text] [Related]  

  • 39. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel psychoactive substances (NPS) - knowledge and expe riences of drug users from Hungary, Poland, the UK and the USA.
    Pisarska A; Deluca P; Demetrovics Z; Moskalewicz J; ReDNet G
    Neuropsychopharmacol Hung; 2019 Dec; 21(4):152-163. PubMed ID: 32015192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.